STOCK TITAN

Omega Healthcare (OHI) director gifts 5,131 shares, retains 17,301

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Omega Healthcare Investors Inc. director Lisa Egbuonu-Davis reported a bona fide gift of 5,131 shares of Common Stock on 2026-08-07. The transaction was recorded at a price of $0.00 per share, and her directly held position after the gift is 17,301 shares.

Positive

  • None.

Negative

  • None.
Insider Egbuonu-Davis Lisa
Role Director
Type Security Shares Price Value
Gift Common Stock 5,131 $0.00 $0.00
Holdings After Transaction: Common Stock — 17,301 shares (Direct)
Shares gifted 5,131 shares Bona fide gift of Common Stock on 2026-08-07
Price per share $0.00 per share Reported value for the gift transaction
Shares held after transaction 17,301 shares Director’s direct holdings following the gift
Bona fide gift regulatory
"The transaction code "G" is described as a bona fide gift."
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
Common Stock financial
"The reported security for the transaction is Common Stock."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 regulatory
"The insider transaction is disclosed on Form 4."
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What transaction did Omega Healthcare (OHI) director Lisa Egbuonu-Davis report?

Lisa Egbuonu-Davis reported a bona fide gift of 5,131 shares of Omega Healthcare Investors Inc. Common Stock on 2026-08-07. The Form 4 classifies this as a gift transaction rather than a market purchase or sale.

How many Omega Healthcare (OHI) shares did the director transfer as a gift?

The director transferred 5,131 shares of Omega Healthcare Investors Inc. Common Stock as a bona fide gift. This non-cash disposition reduced her directly held stake but did not involve any sale proceeds.

What is Lisa Egbuonu-Davis’s Omega Healthcare (OHI) shareholding after the gift?

Following the reported gift, Lisa Egbuonu-Davis directly holds 17,301 shares of Omega Healthcare Investors Inc. Common Stock. This total reflects her position immediately after the 5,131-share gift transaction on 2026-08-07.

Was the Omega Healthcare (OHI) insider transaction a sale or a gift?

The filing identifies the transaction as a bona fide gift, coded "G" on Form 4. No sale price was involved, and the per-share value in the report is shown as $0.00, consistent with a non-cash transfer.

Does the Omega Healthcare (OHI) Form 4 indicate a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not marked as affirmative, and the structured data do not describe this as a plan transaction. The event is reported simply as a bona fide gift of shares by a director.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Egbuonu-Davis Lisa

(Last)(First)(Middle)
303 INTERNATIONAL CIRCLE
SUITE 200

(Street)
HUNT VALLEY MARYLAND 21030

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
OMEGA HEALTHCARE INVESTORS INC [ OHI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/07/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/07/2026G5,131D$017,301D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
/s/ Meghan C. Lyons, Attorney-in-Fact08/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)